China Universal Asset Management Co., Ltd. Reneo Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Reneo Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 6,388 shares of RPHM stock, worth $9,582. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,388
Previous 6,388
-0.0%
Holding current value
$9,582
Previous $11,000
9.09%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RPHM
# of Institutions
67Shares Held
29.4MCall Options Held
125KPut Options Held
3.1K-
Nea Management Company, LLC Timonium, MD4.79MShares$7.18 Million0.56% of portfolio
-
Tang Capital Management LLC San Diego, CA3MShares$4.5 Million0.61% of portfolio
-
Highbridge Capital Management LLC New York, NY2.74MShares$4.1 Million1.03% of portfolio
-
Carlyle Group Inc. Washington, DC2.7MShares$4.05 Million0.33% of portfolio
-
River Vest Venture Management LLC St. Louis, MO2.53MShares$3.8 Million51.67% of portfolio
About Reneo Pharmaceuticals, Inc.
- Ticker RPHM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,479,600
- Market Cap $36.7M
- Description
- Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...